For Quick Alerts
For Daily Alerts

Sun Pharma tanks over 6% on $550 million patent suit settlement with Pfizer

By Religare

Shares of drug maker Sun Pharmaceuticals Industries dipped over 6 per cent in early trade on Bombay Stock Exchange (BSE) after the company said it would pay a USD 2.15 billion to settle a patent infringement lawsuit related to its acid-reflux drug Protonix.

"Under the terms of the litigation settlement between Sun Pharmaand Wyeth (now a division of Pfizer Inc.) and Altana Pharma AG (now known as Takeda GmbH), the parties have dismissed all their claims and Sun Pharma will pay a lump-sum of $550 million (around Rs.3,100 crore) as part of the settlement," Sun Pharma said in a statement.


Weighed down by development, shares of company declined as much 6.62 per cent to trade at Rs 916.00 a piece on the BSE.

In a similar fashion, shares of the company were locked at 955.00 a piece, down 2.62 per cent on the National Stock Exchange (NSE).

Meanwhile, the broader benchmark Sensex was quoting at 18,868.35, down 178.71 points or 0.91 per cent at 9:43 hours.

Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more